Bladder cancer: what’s new in 2019—2020

Abstract

This review aims to summarize the latest data on the treatment of bladder cancer published during the specified period Most of them are evidence-based and were obtained in randomized trials A new classification based on molecular data was proposed at a consensus meeting of pathologists A significant correlation has been demonstrated between life expectancy and morphological structure of the tumor This article covers chemotherapy regimens for patient with BCG (Bacillus Calmette-Guérin) intolerance Immunotherapeutic agents for muscleinvasive bladder cancer are being actively studied now;scientists are searching for the best treatment regimens with these drugs and their combinations with other antitumor agents The European Association of Urology has developed a new classification of intraoperative adverse events and recommendations for pharmacotherapy and surgical treatment of patients with bladder cancer during the COVID-19 pandemic In conclusion, the opinions of experts from the consensus meeting on the treatment of various forms of bladder cancer are given © 2020 ABC-press Publishing House All rights reserved